ROC curve analysis for NKX2-6 CpG3 revealed a sensitivity of 38% for DCIS detection, which was decreased to 25% for breast cancer detection, both at 84% specificity (Supplementary Table 2). Here, NKX2-6 is linked to ductal breast carcinoma in situ.